Literature DB >> 15894144

Assessing the burden of disease in the United States using disability-adjusted life years.

Matthew T McKenna1, Catherine M Michaud, Christopher J L Murray, James S Marks.   

Abstract

OBJECTIVES: Burden of disease studies have been implemented in many countries using the disability-adjusted life year (DALY) to assess major health problems.
METHODS: We applied methods developed by the World Bank and World Health Organization (WHO) to data specific to the United States to compute DALYs. We compared the results of this analysis to international estimates published by WHO for developed and developing regions of the world.
RESULTS: In the mid-1990s, the leading sources of premature death and disability in the United States, as measured by DALYs, were cardiovascular conditions, breast and lung cancers, depression, osteoarthritis, diabetes mellitus, and alcohol use and abuse. In addition, motor vehicle-related injuries and the HIV epidemic exacted a substantial toll on the health status of the U.S. population, particularly among racial/ethnic minorities. The major sources of death and disability in these latter populations were more similar to patterns of burden in developing rather than developed countries.
CONCLUSIONS: This analysis provides the first detailed, comprehensive estimates using DALYs of the fatal and nonfatal conditions that exact large health burdens in the United States.

Entities:  

Mesh:

Year:  2005        PMID: 15894144     DOI: 10.1016/j.amepre.2005.02.009

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  76 in total

1.  The epidemiology of major depression and ethnicity in the United States.

Authors:  Hector M González; Wassim Tarraf; Keith E Whitfield; William A Vega
Journal:  J Psychiatr Res       Date:  2010-05-27       Impact factor: 4.791

2.  Young adults at risk for excess alcohol consumption are often not asked or counseled about drinking alcohol.

Authors:  Ralph W Hingson; Timothy Heeren; Erika M Edwards; Richard Saitz
Journal:  J Gen Intern Med       Date:  2012-02       Impact factor: 5.128

3.  Assessing anxious features in depressed outpatients.

Authors:  Shawn M McClintock; Mustafa M Husain; Ira H Bernstein; Stephen R Wisniewski; Madhukar H Trivedi; David Morris; Jonathan Alpert; Diane Warden; James F Luther; Susan G Kornstein; Melanie M Biggs; Maurizio Fava; A John Rush
Journal:  Int J Methods Psychiatr Res       Date:  2011-11-04       Impact factor: 4.035

4.  Measuring the public's health.

Authors:  Stephen B Thacker; Donna F Stroup; Vilma Carande-Kulis; James S Marks; Kakoli Roy; Julie L Gerberding
Journal:  Public Health Rep       Date:  2006 Jan-Feb       Impact factor: 2.792

Review 5.  Targeted electrode-based modulation of neural circuits for depression.

Authors:  Helen S Mayberg
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808

6.  What is the role of brain stimulation therapies in the treatment of depression?

Authors:  Daniel M Blumberger; Benoit H Mulsant; Zafiris J Daskalakis
Journal:  Curr Psychiatry Rep       Date:  2013-07       Impact factor: 5.285

Review 7.  Mesenchymal stem cells in joint disease and repair.

Authors:  Frank Barry; Mary Murphy
Journal:  Nat Rev Rheumatol       Date:  2013-07-23       Impact factor: 20.543

8.  MRI findings associated with development of incident knee pain over 48 months: data from the osteoarthritis initiative.

Authors:  Gabby B Joseph; Stephanie W Hou; Lorenzo Nardo; Ursula Heilmeier; Michael C Nevitt; Charles E McCulloch; Thomas M Link
Journal:  Skeletal Radiol       Date:  2016-02-27       Impact factor: 2.199

9.  Sensitivity and Specificity in Three Measures of Depression Among Mexican American Women.

Authors:  Dellanira Valencia-Garcia; Xiaoyu Bi; Cecilia Ayón
Journal:  J Immigr Minor Health       Date:  2017-06

10.  Long-term cumulative depressive symptom burden and risk of cognitive decline and dementia among very old women.

Authors:  Adina Zeki Al Hazzouri; Eric Vittinghoff; Amy Byers; Ken Covinsky; Dan Blazer; Susan Diem; Kristine E Ensrud; Kristine Yaffe
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-04       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.